Severe Acute Respiratory Syndrome Coronavirus 2 Epitope Mapping for Antibodies

Author:

Yang Jiaan12,Zhang Peng1ORCID,Cheng Wen Xiang1,Wu Gang3,Niu Qing Tian4ORCID,Yang Lan4,Luo Shun4,Lin Xianghua5,Zhang Lianshan6ORCID

Affiliation:

1. *Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China;

2. †Micro Biotech, Ltd., Shanghai, China;

3. ‡School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China;

4. §Thousand Oaks Biologics Inc., Nantong, Jiangsu, China;

5. ¶Xiamen Changgung Hospital, Xiamen, Fujian, China; and

6. ‖Shanghai Hengrui Pharmaceutical Co. Ltd., Shanghai, China

Abstract

Abstract Epitope mapping of the interactions between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Abs is challenging because of complexity in protein three-dimensional structures. Protein structure fingerprint technology was applied for epitope mapping of 44 SARS-CoV-2 Abs with three-dimensional structure complexes. The results defined how the epitopes were distributed on SARS-CoV-2 and how the patterns of six CDRs from Abs participated in neutralization. Also, the residue–residue recognition revealed that certain residues had higher frequencies on the interfaces between SARS-CoV-2 and Abs, and the activity correlated with the physicochemical properties of the residues at the interface. Thus, epitope mapping provides significant lead information for development of epitope-based designs for Abs, vaccines, and diagnostic reagents. This is a bioinformatics project of structural data analysis; no animals or cells were used.

Publisher

The American Association of Immunologists

Subject

Immunology and Allergy,General Medicine,Immunology

Reference29 articles.

1. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.;Coronaviridae Study Group of the International Committee on Taxonomy of Viruses;Nat. Microbiol.,2020

2. BioRender . COVID-19 Vaccine & Therapeutics Tracker. Available at: https://biorender.com/covid-vaccine-tracker. Accessed: June 4, 2022.

3. La Jolla Institute . CoVIC Dashboard. Available at: https://covic.lji.org/database/. Accessed: June 4, 2022.

4. Coronavirus puts drug repurposing on the fast track.;Harrison;Nat. Biotechnol.,2020

5. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.;Chai;Cochrane Database Syst. Rev.,2020

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3